Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
| ▸ | PRKCA | P17252 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6299651 | 1.00 | NAAA (0.46) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL30894533 | 0.85 | NAAA (0.55) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL10467654 | 0.84 | NAAA (0.43) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL30894534 | 0.84 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL698203 | 0.84 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL9743615 | 0.84 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL10467609 | 0.84 | NAAA (0.56) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL453206 | 0.83 | NAAA (0.54) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL1938967 | 0.80 | NAAA (0.51) | NAAASMN1; SMN2KMT2AMEN1GAA | |
| SCHEMBL1232050 | 0.80 | NAAA (0.66) | NAAASMN1; SMN2KMT2AMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6391949-B1 | — | — | None | — | — | US | disclosed |
| US-6872832-B2 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-03-29 | — | — | US | disclosed |
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2003-06-26 | — | — | US | disclosed |
| US-6420562-B2 | OXIDATION, HEAT AND RADIATION RESISTANCE | CIBA SPECIALITY CHEMICALS CORPORATION | 2002-07-16 | — | — | US | disclosed |
| US-6403681-B2 | STABILIZER FOR PLASTICS | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-11 | — | — | US | disclosed |
| US-6392041-B1 | OXIDATION, HEAT AND RADIATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-6391949-B2 | FOR AUTOMOBILE FINISHES; HEAT, OXIDATION, RADIATION RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-20020058735-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES PETER (US) | 2002-05-16 | — | — | US | disclosed |
| US-20020040145-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2002-04-04 | — | — | US | disclosed |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-25 | — | — | US | disclosed |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-10-18 | — | — | US | disclosed |
| US-20010020099-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-09-06 | — | — | US | disclosed |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | GALBO JAMES P (US) | 2001-08-30 | — | — | US | disclosed |
| US-6271377-B1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-08-07 | — | — | US | disclosed |
| US-6166212-A | Process for the synthesis of N-(hydroxyalkoxy) substituted hindered amine stabilizers | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2000-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040145-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
| US-20020058735-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | OGG1, HAO2, POLH | NAAA 1048/4885SMN1; SMN2 611/4885KMT2A 609/4885 |
| US-20010034449-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
| US-20010020099-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
| US-20030120077-A1 | Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith | OGG1, POLH, OGFOD1 | NAAA 925/4885SMN1; SMN2 552/4885KMT2A 615/4885 |
| US-20010018520-A1 | Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
| US-20010031872-A1 | Hydroxy-substituted N-Alkoxy hindered amines and compositions stabilized therewith | POLH, OGG1, OGFOD1 | NAAA 1325/4885SMN1; SMN2 595/4885KMT2A 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.